Tag Archives: anti-corruption
Compliance and Disclosure Risks on Anti-Competitive Promotional Spend: Is EuroLand Set to Follow the US?
By William Looney | Published: November 24, 2010
New Cegedim survey documents whether European industry is ready for the challenge. Making sense of the promotional spend and anti-corruption compliance burden is emerging as a key strategic issue for pharma — not just in the US but in the global market space as well, where regulatory safeguards are still porous. New survey research just published [...]